Pretargeted immunoPET with Immunomedics' TF2 and gallium-68 (68Ga)-labeled peptide is a sensitive imaging method for colon cancer and is more specific than FDG PET, according to results presented at the annual meeting of the American Association for Cancer Research (AACR) this week in Orlando, Fla.